Based on the huge drug use in this disease, the quick changes in clinical symptoms observed in this clinical trial and the easy possibility of carrying out a screening and detection of HIT or DAO deficiency, the supplementation with exogenous DAO could be and potential therapeutic approach in fibromyalgia. This evidence concerns the gene DAO and fibromyalgia.